Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boryung Pharmaceutical Co., Ltd
* Multi-center, randomized, prospective, double blind, active control, parallel study
* Superiority study (Treatment group - Cilnidipine/Control group - Nifedipine)
* Measure the effects of Cinalong(TM) after 3 month and 12 month-application
Age
30–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Men or women, 30-65 years of age having essential hypertension with metabolic syndrome
2. At Screening and Visit 1, blood pressure should be: sitting systolic blood pressure (SiSBP) \>=140 mmHg or sitting diastolic blood pressure (SiDBP)\>= 90 mmHg and two or more of the following criteria should apply.
* Abdominal obesity: waist circumference \>= 90 cm in men and \>= 80 cm in women